On 12 February 2025, the Rapid Bio team welcomed a delegation from Myanmar led by Si Tu Aung, Chairman of the Board of Directors of CAG Group of Companies.
CAG, a major investment force in Southeast Asia, operates across several strategic sectors in Myanmar, including energy, engineering, and medical technology.
The visitors received a warm welcome and were given an in‑depth tour of Rapid Bio’s cutting‑edge laboratories and production facilities.
Bilateral talks followed, featuring Rapid Bio Co‑Founder and Chief Commercial Officer Simon Pokatsky. The two sides set priorities for further collaboration, explored the possibility of localizing production in Myanmar, and evaluated the investment potential of Russian medical devices and technologies.
Rapid Bio is confident that this partnership will open new horizons and yield substantial benefits for both parties.